Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Baird Downgrades IBEX to Neutral, Maintains Price Target to $30

Author: Benzinga Newsdesk | May 12, 2025 10:01am
Baird analyst David Koning downgrades IBEX (NASDAQ:IBEX) from Outperform to Neutral and maintains the price target from $30 to $30.

Posted In: IBEX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist